J. Robert Coleman

Co-Founder & CEO at Codagenix

Dr. Coleman is an entrepreneurial synthetic biologist who co-founds Codagenix, Inc. to commercialize the genome design platform for vaccine development he co-invented. Dr. Coleman has overseen the raising of $42M and securing partnerships in the agricultural vaccine space. Dr. Coleman led Codagenix’s influenza vaccine candidate from bench to bedside, where it is currently being tested in Phase I/II human trials. Dr. Coleman leads all aspects of the Codagenix business. Dr. Coleman is a skilled and creative microbiologist who has made pivotal advances in synthetic biology (Science 2008). His work possesses a unique vision and he is passionate about utilizing rational gene design to solve pertinent medical issues and emergent biothreats. Dr. Coleman holds a BS from Tulane University, a Ph.D. from Stony Brook University, and an MBA from the New York Institute of Technology.


  • Co-Founder & CEO

    Current role


By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.